Early-life seizures may prematurely switch on key synapses in the brain that may further cause neurodevelopmental delay among children with autism and other intellectual disabilities, finds a new study.
According to the researchers, antiepileptic drug may keep those synapses "silent" longer so brain can develop normally.
The results, revealed a mechanism for the relationship between seizures and later-in-life cognitive impairment, as well as a much-needed potential treatment avenue to pursue.
"Understanding the precise synaptic changes following seizures gives an opportunity to find treatments that can prevent this early 'unsilencing'," said Frances E. Jensen from Perelman School of Medicine at the University of Pennsylvania.
"The timing is important: We need to stop it right after the seizures and before a critical period of development in a child's life so the brain can develop without any problems that may lead to future impairments," Jensen added.
In the study, published in the journal Cell Reports, the team induced seizures in mice with pentylenetetrazol, or PTZ, injections and used voltage-sensitive dye (VSD) imaging to monitor, measure, and visualise brain activity in the auditory cortex.
The results showed that following induced seizures "silent" thalamocortical synapses - the main route of sensory information to the cerebral cortex -- in the auditory cortex - part that possess auditory information-- containing only NMDA receptors, switched to "unsilent" synapses with both NMDA and AMPA receptors -- receptors play important roles in learning and forming new memories.
Further investigations showed that treatment using a drug called NBQX, reduced AMPA receptor enhancement and premature "unsilencing" of the thalamocortical synapses, and also restored synaptic plasticity during the critical period, the researchers reported.
"This is proof of principle that synaptic plasticity is a dynamic target for the treatment of autism and intellectual disabilities that accompany early-life seizures," Jensen added.
--IANS
sh/rt/ksk/vm
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
